Cargando…

Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion

Detalles Bibliográficos
Autores principales: Gaule, Marina, Pesoni, Camilla, Quinzii, Alberto, Zecchetto, Camilla, Casalino, Simona, Merz, Valeria, Contarelli, Serena, Pietrobono, Silvia, Vissio, Elena, Molinaro, Luca, Manzin, Enrica, Volpatto, Roberta, Vellani, Giorgio, Melisi, Davide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769132/
https://www.ncbi.nlm.nih.gov/pubmed/35005993
http://dx.doi.org/10.1200/PO.21.00400
_version_ 1784635063149789184
author Gaule, Marina
Pesoni, Camilla
Quinzii, Alberto
Zecchetto, Camilla
Casalino, Simona
Merz, Valeria
Contarelli, Serena
Pietrobono, Silvia
Vissio, Elena
Molinaro, Luca
Manzin, Enrica
Volpatto, Roberta
Vellani, Giorgio
Melisi, Davide
author_facet Gaule, Marina
Pesoni, Camilla
Quinzii, Alberto
Zecchetto, Camilla
Casalino, Simona
Merz, Valeria
Contarelli, Serena
Pietrobono, Silvia
Vissio, Elena
Molinaro, Luca
Manzin, Enrica
Volpatto, Roberta
Vellani, Giorgio
Melisi, Davide
author_sort Gaule, Marina
collection PubMed
description
format Online
Article
Text
id pubmed-8769132
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-87691322022-01-20 Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion Gaule, Marina Pesoni, Camilla Quinzii, Alberto Zecchetto, Camilla Casalino, Simona Merz, Valeria Contarelli, Serena Pietrobono, Silvia Vissio, Elena Molinaro, Luca Manzin, Enrica Volpatto, Roberta Vellani, Giorgio Melisi, Davide JCO Precis Oncol Case Reports Wolters Kluwer Health 2022-01-05 /pmc/articles/PMC8769132/ /pubmed/35005993 http://dx.doi.org/10.1200/PO.21.00400 Text en © 2022 by American Society of Clinical Oncology https://creativecommons.org/licenses/by-nc-nd/4.0/Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: https://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Case Reports
Gaule, Marina
Pesoni, Camilla
Quinzii, Alberto
Zecchetto, Camilla
Casalino, Simona
Merz, Valeria
Contarelli, Serena
Pietrobono, Silvia
Vissio, Elena
Molinaro, Luca
Manzin, Enrica
Volpatto, Roberta
Vellani, Giorgio
Melisi, Davide
Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion
title Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion
title_full Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion
title_fullStr Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion
title_full_unstemmed Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion
title_short Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion
title_sort exceptional clinical response to alectinib in pancreatic acinar cell carcinoma with a novel alk-kank4 gene fusion
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769132/
https://www.ncbi.nlm.nih.gov/pubmed/35005993
http://dx.doi.org/10.1200/PO.21.00400
work_keys_str_mv AT gaulemarina exceptionalclinicalresponsetoalectinibinpancreaticacinarcellcarcinomawithanovelalkkank4genefusion
AT pesonicamilla exceptionalclinicalresponsetoalectinibinpancreaticacinarcellcarcinomawithanovelalkkank4genefusion
AT quinziialberto exceptionalclinicalresponsetoalectinibinpancreaticacinarcellcarcinomawithanovelalkkank4genefusion
AT zecchettocamilla exceptionalclinicalresponsetoalectinibinpancreaticacinarcellcarcinomawithanovelalkkank4genefusion
AT casalinosimona exceptionalclinicalresponsetoalectinibinpancreaticacinarcellcarcinomawithanovelalkkank4genefusion
AT merzvaleria exceptionalclinicalresponsetoalectinibinpancreaticacinarcellcarcinomawithanovelalkkank4genefusion
AT contarelliserena exceptionalclinicalresponsetoalectinibinpancreaticacinarcellcarcinomawithanovelalkkank4genefusion
AT pietrobonosilvia exceptionalclinicalresponsetoalectinibinpancreaticacinarcellcarcinomawithanovelalkkank4genefusion
AT vissioelena exceptionalclinicalresponsetoalectinibinpancreaticacinarcellcarcinomawithanovelalkkank4genefusion
AT molinaroluca exceptionalclinicalresponsetoalectinibinpancreaticacinarcellcarcinomawithanovelalkkank4genefusion
AT manzinenrica exceptionalclinicalresponsetoalectinibinpancreaticacinarcellcarcinomawithanovelalkkank4genefusion
AT volpattoroberta exceptionalclinicalresponsetoalectinibinpancreaticacinarcellcarcinomawithanovelalkkank4genefusion
AT vellanigiorgio exceptionalclinicalresponsetoalectinibinpancreaticacinarcellcarcinomawithanovelalkkank4genefusion
AT melisidavide exceptionalclinicalresponsetoalectinibinpancreaticacinarcellcarcinomawithanovelalkkank4genefusion